Daily routine
Saxenda follows a daily injection pattern rather than a weekly one, so convenience and confidence with self-injection matter more.
Saxenda is the brand name for liraglutide, a prescription-only GLP-1 medicine used for weight management in the UK. It is taken as a daily injection, which makes it different from newer weekly options such as Wegovy and Mounjaro.
Saxenda is still a genuine UK treatment route, but it now sits as an older alternative in a market led more heavily by weekly injections. That does not make it irrelevant. It does mean the practical comparison usually starts with dosing routine, long-term cost, and how clearly a provider explains the route.
The biggest day-to-day difference is simple: Saxenda is injected every day, while Wegovy and Mounjaro are usually taken weekly. For some people that routine matters just as much as the headline price.
Saxenda follows a daily injection pattern rather than a weekly one, so convenience and confidence with self-injection matter more.
It remains part of the UK conversation, but it is no longer the route most private comparison visitors start with.
Clear prescribing checks, delivery information and follow-up support matter more than a loose “available now” claim.
Saxenda is a daily liraglutide injection. Wegovy is a weekly semaglutide injection. Mounjaro is a weekly tirzepatide injection.
Saxenda usually comes up as an established older alternative rather than the main route people shortlist first for private treatment.
Look beyond the first visible fee. Check how the provider handles eligibility, follow-up, repeat supply, storage and ongoing support.
Make sure the route sits behind a real consultation and regulated prescribing process rather than a loose checkout flow.
Check how the provider describes cold-chain handling, dispatch timing and what happens if delivery is delayed.
Daily-injection treatment can feel different over time, so check repeat pricing, delivery charges and any later-stage support costs.
Look for clear explanation on side-effect support, missed-dose guidance and how easy it is to contact the provider after approval.
See the weekly semaglutide route that now carries much of the private weight-loss comparison market.
Review the weekly tirzepatide route before comparing Saxenda only on routine or price.
Use the wider cost page to compare recurring treatment costs more carefully.
Check how pharmacy-led and online-doctor routes can differ before choosing where to apply.
MHRA/GOV.UK includes liraglutide among licensed GLP-1 medicines and warns about illegitimate supply channels.
Checked: 25 April 2026 Confidence: High
Source: GLP-1 medicines: what you need to know - GOV.UK / MHRA
Use cautious availability language.
Treatment next step
Treatment pages attract strong intent, but the useful next step is usually the clinic comparison, provider evidence and a broader look at how treatments differ in practice.
No. The site can help you compare routes and questions to ask, but suitability depends on clinical assessment by a regulated provider.
The parent site covers broad route decisions. Wego and Jaro remain the specialist sites for deeper Wegovy and Mounjaro provider detail.
No. Prices, delivery costs, offer terms, eligibility and availability can change. Always confirm current information directly with the provider.
No. It is informational and comparison-led. It does not sell, prescribe or supply prescription-only medicines.